Skip to content

Clinical trials

Phase 4 COVID-19 trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Phase: Phase 4 Country / region: China Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20204
202128
20228
20236

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status23
Completed22
Suspended1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
China National Biotec Group Company Limited10
Sinovac Research and Development Co., Ltd.9
Jiangsu Province Centers for Disease Control and Prevention8
Sinovac Life Sciences Co., Ltd.4
Sinovac Biotech Co., Ltd3
Shandong Provincial Hospital2
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.1
Beijing 302 Hospital1
Chinese Medical Association1
Chinese PLA General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-1947
Bronchitis, Chronic3
HIV Infections3
Pulmonary Disease, Chronic Obstructive3
Influenza, Human2
Atherosclerosis1
Chickenpox1
Coronavirus Infections1
Cough1
Endocrine System Diseases1

Trials

Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.